Name of the Procedure:

Injection, eptinezumab-jjmr, 1 mg (HCPCS Code: J3032)

Summary

Eptinezumab-jjmr is a medication administered via injection that is used to prevent migraine headaches. This treatment involves injecting a specific dosage of eptinezumab-jjmr, which targets and neutralizes a protein linked to migraine onset.

Purpose

Eptinezumab-jjmr is used primarily to reduce the frequency and severity of migraine attacks. The main goal of the procedure is to provide long-term relief from migraines, improving the patient's quality of life.

Indications

This procedure is recommended for patients who experience frequent and severe migraines. Candidates for the injection typically include those who have not responded well to other preventive treatments.

Preparation

Before the procedure, patients may need to:

• Avoid certain medications as advised by their healthcare provider.
• Undergo general health assessments or baseline diagnostic tests.
• Discuss their medical history and current medications with their healthcare provider.

Procedure Description

1. Patient checks in and is brought to a comfortable setting.
2. The injection site is cleaned and prepped.
3. Eptinezumab-jjmr is injected intravenously.
4. Monitoring for any immediate adverse reactions takes place before the patient is discharged.

Duration

The injection process typically takes about 30 minutes, including preparation and monitoring.

Setting

This procedure is usually performed in a healthcare provider's office, outpatient clinic, or specialized headache treatment center.

Personnel

• Nurse or medical assistant to prepare and administer the injection.
• Healthcare provider overseeing the procedure (e.g., neurologist, headache specialist).

Risks and Complications

• Common: Injection site pain or redness, itching, and minor allergic reactions.
• Rare: Severe allergic reactions (anaphylaxis), infections at the injection site, tool including incorrect dosage administration.

Benefits

Many patients experience a significant reduction in the frequency and intensity of migraines within weeks of the injection. Continued treatments can lead to sustained benefits.

Recovery

• Most patients can return to their regular activities immediately after the injection.
• Patients should follow any specific post-procedure instructions provided by their healthcare provider.
• Any adverse reactions should be reported immediately to a healthcare provider.

Alternatives

• Oral migraine preventive medications
• Other injectable treatments (e.g., botulinum toxin injections)
• Non-pharmacological approaches like lifestyle changes or biofeedback therapies Patients should discuss the pros and cons of each alternative with their healthcare provider to determine the best course of action.

Patient Experience

Patients may feel a brief sting or discomfort at the injection site. Most report minimal pain, and healthcare providers often take measures to ensure maximum comfort. After the procedure, any discomfort typically subsides quickly, allowing patients to resume their day with minimal disruption.